Vinay Prasad, an academic and fierce critic of the medical mainstream, has been chosen to be the next director of the FDA ...

“Potential exposure to these substances is still quite small, thank goodness,” Jim Crotty, who served for over a decade in ...

The FTSE 100’s record run was poised to come to an end on Wednesday as pharma stocks slumped on the back of a controversial ...

In today's newsletter: India launches airstrikes inside Pakistan in an escalation of tensions between the two counties. The ...

Canada's new prime minister, Mark Carney, is meeting with President Donald Trump in the Oval Office, a week after winning the ...

Vinay Prasad named to replace Peter Marks as head of FDA's Center for Biologics Evaluation and Research; discussion planned ...

The latest on trade talks, Real ID requirements for travel, pharma stocks tumble, and more news to start your day.

Britain's main indexes fell on Wednesday, with healthcare and real estate stocks leading the decline despite positive trade ...

How did biopharma stocks react to Vinay Prasad’s appointment as director of one of the FDA's top jobs? Not well. Prasad, a ...

Vinay Prasad, an oncologist-hematologist, has been appointed as the new director of the FDA's CBER, overseeing vaccines and ...

Find insight on Novo Nordisk, Siemens Healthineers, Fresenius and more in the latest Market Talks covering Health Care.

Mini futures (ESM25) are up +0.58%, andJune Nasdaq 100 E-Mini futures (NQM25) are up +0.64% this morning as optimism around U ...